Cancer discovery
-
A neoantigen derived from mutant IDH1 can promote antitumor CD4(+) T-cell and antibody responses.
-
Cancer Research UK's expanded 5-year funding strategy includes an annual award for mid-career scientists providing £1.5 million ($2.3 million) over 6 years to cover the costs of running a lab.